With specialty medication costs adding up to 55% of medication spending in the U.S., it’s obvious that self-funded plan sponsors need a helping hand to combat these growing costs.
In a recent interview with Formulary Watch, Bradley Nelson, Senior Director of Clinical Services at RxBenefits, shared that we’ve come to a crossroads with specialty medications.
“They provide life-changing therapeutics for members who have complex conditions and for rare diseases, but the set price points for these are extremely expensive,” Bradley said. “Plans are having a difficult time affording the benefit.”
Read the full interview to learn more about how RxBenefits and our preferred partners are helping tackle these issues with programs that are top of mind for many employers.
